0001564590-19-002328 Sample Contracts

STOCK PURCHASE AGREEMENT By and Between NEUROCRINE BIOSCIENCES, INC. AND VOYAGER THERAPEUTICS, INC. Dated as of January 28, 2019
Stock Purchase Agreement • February 8th, 2019 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware

THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of January 28, 2019 (the “Signing Date”), by and between Neurocrine Biosciences, Inc. (the “Investor”), a Delaware corporation with its principal place of business at 12780 El Camino Real, San Diego, CA 92130, and Voyager Therapeutics, Inc. (the “Company”), a Delaware corporation, with its principal place of business at 75 Sidney Street, Cambridge, MA 02139.

Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs
INVESTOR AGREEMENT By and Between NEUROCRINE BIOSCIENCES, INC. AND VOYAGER THERAPEUTICS, INC. Dated as of January 28, 2019
Investor Agreement • February 8th, 2019 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware

THIS INVESTOR AGREEMENT (this “Agreement”) is made as of January 28, 2019, by and between Neurocrine Biosciences, Inc. (the “Investor”), a Delaware corporation with its principal place of business at 12780 El Camino Real, San Diego, CA 92130, and Voyager Therapeutics, Inc. (the “Company”), a Delaware corporation, with its principal place of business at 75 Sidney Street, Cambridge, MA 02139.

Sample 1Sample 2Sample 3See All (4)
COLLABORATION AND LICENSE AGREEMENT By and between VOYAGER THERAPEUTICS, INC. AND NEUROCRINE BIOSCIENCES, INC.
Stock Purchase Agreement • February 8th, 2019 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York

This COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of January 28, 2019 (the “Execution Date”), by and between Voyager Therapeutics, Inc., a Delaware corporation, having its principal place of business at 75 Sidney Street, Cambridge, MA 02139 (“Voyager”), and Neurocrine Biosciences, Inc., a Delaware corporation, having its principal place of business at 12780 El Camino Real, San Diego, CA 92130 (“Neurocrine”). Voyager and Neurocrine shall be referred to herein individually as a “Party” and collectively as the “Parties”.

Sample 1
COMMERCIAL API SUPPLY AGREEMENT BETWEEN AND
Commercial Supply Agreement • February 8th, 2019 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.